Cybin is shedding its old identity, evolving into Helus Pharma as part of changes that will see its shares move to a different stock exchange. The Toronto-based biotech plans to stop trading on NYSE ...

As 2025 closes, biopharma and healthcare are learning to live on shifting ground. In this special year-end episode of "The Top Line," Fierce reporters take stock of a year defined by federal research ...

Drugmakers to cut prices on most drugs sold to the Medicaid program U.S. patients pay the most for prescription medicines Dec 19 (Reuters) - U.S. President Donald Trump and nine major pharmaceutical ...

Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high ...

Fierce Pharma Week 2025, 8 th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events. For the first time, Questex is bringing together marketing, ...

You may be concerned about the recent declines in AI stocks such as NVDA. However, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns, and doing ...

The investment seeks capital appreciation. The fund normally invests at least 80% of assets in companies engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and ...

UK health regulator approves higher dose of Novo's Wegovy for obesity patients Britain's health regulator said on Friday it had approved a maximum weekly dose of up to 7.2 milligrams of Novo Nordisk's ...

As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...

Since our founding in 2000, we've produced tens of thousands of marketing resources. (So many that even our editors have a hard time keeping up!) That's why we've set up our resource page so you can ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Khadija Khartit is a strategy, investment, and ...

These games are all about being the one in charge, and we all think we'd do a better job. If, like us, you also want a shot at being in the hot seat, we've found the best management games to let you ...